Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSAPREPITANT vs FOSCARBIDOPA\FOSLEVODOPA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSAPREPITANT vs FOSCARBIDOPA\FOSLEVODOPA: Safety Overview

Metric FOSAPREPITANT FOSCARBIDOPA\FOSLEVODOPA
Total FAERS Reports 487 3,161
Deaths Reported 154 431
Death Rate 31.6% 13.6%
Hospitalizations 264 1,747
Average Patient Age 49.6 yrs 70.4 yrs
% Female Patients 83.0% 42.2%